UT Dallas acquires new microCT-enhanced deep-tissue Optical Imaging system.
The Department of Bioengineering at the UT Dallas is adding a MILabs Hybrid OI/CT system to its innovative medical imaging solutions. By fusing bioluminescent and fluorescent imaging with ultra-high-resolution CT, this new in-vivo imaging system …
MILabs Selected by Columbia University Irving Medical Center For Upgrades to its Molecular Imaging Capabilities
Utrecht, the Netherlands, February 15, 2019 The MILabs VECTor (OI/CT) system has been acquired by the Department of Radiology at Columbia University Irving Medical Center (CUIMC) to upgrade its molecular imaging capabilities. MILabs VECTor system …
The Baker Heart & Diabetes Institute invests in MILabs’ in-vivo Hybrid Optical/CT tomography to support its groundbreaking platelet research
Melbourne, Australia, and Utrecht, the Netherlands, April 24 2019 – The Baker Heart and Diabetes Institute, an independent Australian-based research institute recognized internationally for its groundbreaking work on the function of platelets in heart disease …
MILabs installs new E-Class SPECT/CT system to enhance heart failure research at the Comprehensive Heart Failure Center (CHFC), Würzburg, Germany
Würzburg, Germany and Utrecht, the Netherlands The nuclear cardiology core facility of the CHFC-Würzburg has acquired MILabs E-class SPECT/CT system to enhance its existing top-level basic, translational and clinical research activities in the field of …
MILabs announces the first installation in Poland of its pre-clinical Adaptive microCT scanner
The Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology (FBBB) at the Jagiellonian University in Kraków recently became the first institute in Poland to install MILabs’ Adaptive U-CT for in-vivo preclinical imaging. To accommodate …
Barts Cancer Institute at Queen Mary University of London upgrades its imaging facility with MILabs VECTor PET/SPECT/CT
Utrecht/London March 20 2019 – Milabs B.V., manufacturer of the world’s only fully integrated SPECT/PET/Optical/CT-scanner, today announces that the core molecular imaging facility at Queen Mary University of London’s Barts Cancer Institute (BCI) has boosted …
Join MILabs at our Industry Session at EMIM
Next week Thursday, during the EMIM in Glasgow, MILabs will be hosting a free Industry Session. Join us and watch the presentations of: Freek Beekman, MILabs Felix Gremse, RWTH Aachen Behdad Pouran, UMC Utrecht James …
RWTH Aachen’s ExMI Institute expands molecular imaging capabilities with MILabs’ Integrated Optical/CT system
Aachen, Germany and Utrecht, the Netherlands – February 25, 2019 MILabs B.V. is pleased to announce that the Institute of Experimental Molecular Imaging (ExMI) at the RWTH Aachen University has chosen the MILabs high resolution …
MILabs’ VECTor6 with groundbreaking PET performance awarded Innovation of the Year at the WMIC 2018
September 15, Seattle, USA MILabs is pleased to announce that its new VECTor6 with Broadband Photon Tomography technique has received the Commercial Innovation Award at the World Molecular Imaging Congress (WMIC) in Seattle September 12th-15th, …
MILabs Broadband Photon Tomography nominated for Innovation of the Year – WMIC 2018
September 4, Seattle, USA, and Utrecht, the Netherlands MILabs is pleased to announce that its new Broadband Photon Tomography technique has been nominated for the Innovation of the Year 2018 award by the World Molecular …
University of Sydney acquires state-of-the-art MILabs preclinical in-vivo X-ray CT
Sydney, Australia, and Utrecht, the Netherlands, August 31st, 2018 MILabs announces that it has successfully completed the installation of its next-generation Adaptive U-CTXUHR at Sydney Imaging, a Core Research Facility of the University of Sydney. Recognizing …
The Hebrew University of Jerusalem installs MILabs’ dual-energy, high-resolution microCT for imaging drug delivery.
Jerusalem, Israel, and Utrecht, the Netherlands, July 30th, 2018 A MILabs dual-energy, ultra-high resolution U-CT system has been installed at the Hebrew University of Jerusalem Israel (HUJI). Under the direction of Professor Galia Blum, this …
